10x Genomics Inc (NAS:TXG)
$ 23.95 -0.88 (-3.54%) Market Cap: 2.87 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 4.13 GF Score: 75/100

Q4 2021 10X Genomics Inc Earnings Call Transcript

Feb 16, 2022 / 09:30PM GMT
Release Date Price: $94.98 (-0.34%)
Operator

Hello, good afternoon, and welcome to the 10x Genomics Fourth Quarter 2021 Earnings Call. My name is Gemma, and I will be the operator for today. (Operator Instructions) I'll now hand over to our host, Eric Jaschke. Please go ahead. Thank you.

Eric Allen Jaschke
10x Genomics, Inc. - Senior Director of IR & Strategic Finance

Thank you. Earlier today, 10x Genomics released financial results for the full year and fourth quarter ended December 31, 2021. If you've not received this news release or if you'd like to be added to the company's distribution list, please send an e-mail to [email protected]. An archived webcast of this call will be available on the Investor tab of the company's website, 10xgenomics.com for at least 45 days following this call.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot